After a harrowing summer, will Bengaluru’s water future change?
As the city continues to face a crisis, industries must focus on sustainable methods of using and discarding water. Using recycled…
Author
Lupin gains tentative FDA approval for Empagliflozin, Linagliptin, Metformin Hydrochloride ER…
This product will be manufactured at Lupin’s Pithampur facility in India
Alembic gets US FDA nod for Bromfenac Ophthalmic Solution, 0.07 per cent
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Prolensa Ophthalmic Solution, 0.07 per…
VNS and cenobamate combo therapy success paves way for cenobamate monotherapy, says GlobalData
The combination therapy demonstrated significant improvements in seizure control, highlighting its potential as a safe and…
J&J receives full approval from US FDA and European Commission for SIRTURO
With the FDA’s approval, label restrictions that were included when the medicine was granted accelerated approval in the US in…
Novo Holdings co-leads £90 million Series A financing for Myricx Bio
The funds will be used to build out Myricx Bio’s proprietary payload platform and advance its pipeline through clinical proof of…
FDA updates guidance to address spread of misinformation
The revised draft supports the efforts of medical product companies that share this interest in helping the public get factual,…
Transforming India’s pharma sector: Opportunities and Innovations under Modi 3.0
Anil Matai, Director General, OPPI shares an optimistic outlook for further enhancements in quality healthcare through continued…
Pharma industry experts eye budget boost for innovation and global ambitions
In anticipation of the upcoming Union Budget on July 23 2024, India's $50 billion pharmaceutical industry is seeking a…
Industry reports 76 deals worth $5B in June 2023: GlobalData
The pharma industry reported 88 VC deals worth $2.5B in June 2024, compared to the last 12-month (June 2023 to May 2024) average…